Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Burnham awarded $7.39 million for study on Neuron-Glia communication in development

Burnham awarded $7.39 million for study on Neuron-Glia communication in development

Lexicon-Genentech reveals potential therapeutic targets

Lexicon-Genentech reveals potential therapeutic targets

Lexicon Reports on anti-angiogenesis target discoveries

Lexicon Reports on anti-angiogenesis target discoveries

Thrombogenics announces agreement with Millipore for commercialization of stem cell technology

Thrombogenics announces agreement with Millipore for commercialization of stem cell technology

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Use of computer-assisted drug design in drug discovery

Use of computer-assisted drug design in drug discovery

Alteon expands agreement with Biorap Technologies

Alteon expands agreement with Biorap Technologies

Roche to acquire BioVeris

Roche to acquire BioVeris

Method for making new molecules based on flavonoids - implications for cancer therapeutics

Method for making new molecules based on flavonoids - implications for cancer therapeutics

Eli Lilly acquires Hypnion

Eli Lilly acquires Hypnion

First time observing real-time molecular interplay within ribosome

First time observing real-time molecular interplay within ribosome

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research granted two new U.S. patents for antibodies

Lilly to acquire neuroscience drug discovery co. Hypnion

Lilly to acquire neuroscience drug discovery co. Hypnion

Fox Chase Cancer Center and Cancer Research Technology initiate drug discovery collaboration

Fox Chase Cancer Center and Cancer Research Technology initiate drug discovery collaboration

PPD licenses dyslipidemia statin from Ranbaxy

PPD licenses dyslipidemia statin from Ranbaxy

New patented technology for next generation of DNA and RNA microarrays

New patented technology for next generation of DNA and RNA microarrays

New technologies boost production of malaria drug artemisinin

New technologies boost production of malaria drug artemisinin

Natural molecules to create pseudo-cell factories

Natural molecules to create pseudo-cell factories

Ranbaxy and GlaxoSmithKline form alliance

Ranbaxy and GlaxoSmithKline form alliance

4SC granted U.S. patent for drug to treat rheumatoid arthritis

4SC granted U.S. patent for drug to treat rheumatoid arthritis